Who owns MARKER THERAPEUTICS INC COM NEW?
- Ticker: MRKR
- CUSIP Number: 57055l206
Tip: Access positions for across all investors
Analyze quarterly positions in Marker Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Marker Therapeutics stock
Who bought or sold MARKER THERAPEUTICS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 1.6M | $2.4M | 0% | Jun 2026 |
|
| Blue Owl Capital Holdings | 554k | $815k | 0% | Jun 2026 |
|
| Vanguard Capital Management | 426k | $627k | 9% | Jun 2026 |
|
| Aisling Capital Management | 325k | $478k | 0% | Jun 2026 |
|
| Renaissance Technologies | 249k | $367k | 42% | Jun 2026 |
|
| Geode Capital Management | 140k | $206k | -13% | Jun 2026 |
|
| Advisor Group Holdings | 113k | $166k | 21% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 87k | $128k | 0% | Jun 2026 |
|
| LPL Financial | 83k | $122k | 0% | Jun 2026 |
|
| Concurrent Investment Advisors | 68k | $100k | 100% | Jun 2026 |
|
| Two Sigma Investments | 60k | $89k | -1% | Jun 2026 |
|
| XTX Topco | 45k | $67k | -29% | Jun 2026 |
|
| Northern Trust | 35k | $51k | 33% | Jun 2026 |
|
| Citadel Advisors | 33k | $48k | 100% | Jun 2026 |
|
| State Street Corporation | 21k | $27k | 0% | Mar 2026 |
|
| Invst | 18k | $27k | -38% | Jun 2026 |
|
| Creative Planning | 17k | $25k | 0% | Jun 2026 |
|
| Jane Street | 17k | $25k | -54% | Jun 2026 |
|
| Ashton Thomas Private Wealth | 16k | $24k | 0% | Jun 2026 |
|
| Virtu Financial | 12k | $17k | 100% | Jun 2026 |
|
| Fifth Third Bancorp | 10k | $15k | 0% | Jun 2026 |
|
| UBS Group | 8.2k | $12k | -75% | Jun 2026 |
|
| Vanguard Global Advisers | 2.5k | $3.7k | 0% | Jun 2026 |
|
| International Assets Investment Management | 2.0k | $2.9k | 0% | Jun 2026 |
|
| Tower Research Capital | 810.00 | $1.2k | -74% | Jun 2026 |
|
| Wells Fargo & Company | 232.00 | $340.993600 | 0% | Jun 2026 |
|
| Signature | 228.00 | $335.000400 | 0% | Jun 2026 |
|
| SBI Securities | 203.00 | $298.004000 | 0% | Jun 2026 |
|
| Group One Trading | 178.00 | $261.998200 | 0% | Jun 2026 |
|
| Hilltop National Bank | 73.00 | $107.003400 | 0% | Jun 2026 |
|
| Barclays | 63.00 | $93.000600 | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 23.00 | $34.000900 | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 23.00 | $34.000900 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 9.00 | $12.999600 | 200% | Jun 2026 |
|
| Morgan Stanley | 2.00 | $2.000000 | -87% | Mar 2026 |
|
Who sold out of Marker Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Mar 2026 | 49k | $63k |
| Matrix Asset Advisors | Mar 2026 | 15k | $20k |
| Hrt Financial | Mar 2026 | 12k | $15k |
| Two Sigma Securities | Mar 2026 | 12k | $15k |